CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab-Reference-Cited by-同舟云学术

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

Published:2006-12-12 Issue:7 Volume:56 Page:1107-1117
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

DiJoseph John F.,Dougher Maureen M.,Armellino Douglas C.,Kalyandrug Lyka,Kunz Arthur,Boghaert Erwin R.,Hamann Philip R.,Damle Nitin K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-006-0260-5.pdf

Reference38 articles.

1. Damle NK (2004) Tumor-targeted chemotherapy with immunoconjugates of calicheamicin. Expert Opin Biol Ther 4:1445–1452

2. Bross PF, Beitz J, Chen G et al (2001) Gemtuzumab ozogamicin: approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res 7:1490–1496

3. Sievers EL, Appelbaum FR, Spielberger RT et al (1999) Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood 93:3678–3684

4. Sievers E, Larson R, Stadmauer E et al (2001) Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol 19:3244–3254

5. Hamann PR, Hinman LM, Hollander I et al (2002) A potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconj Chem 13:47–58

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technology Advancement in Development of Antibody Drug Conjugates;PROG BIOCHEM BIOPHYS;2023

2. Antibody-drug Conjugate Targets, Drugs, and Linkers;Current Cancer Drug Targets;2022-07

3. Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate;European Journal of Medicinal Chemistry;2022-02

4. Non-internalising antibody–drug conjugates;Chemical Society Reviews;2022

5. Rituximab-drug Conjugate Incorporating Auristatin E via A Quaternary Ammonium Linker Inducing Potent Antitumor Activity Against Non-Hodgkin’s B-cells;Letters in Drug Design & Discovery;2021-10-13